LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

A Tool to Assess Participation in People with COPD: Validation of the Late Life Disability Instrument.

Photo by cieloadentro from unsplash

BACKGROUND Participation in life roles is a critical patient-centred health outcome associated with morbidity and mortality in older adults but it is not routinely measured in people with chronic obstructive… Click to show full abstract

BACKGROUND Participation in life roles is a critical patient-centred health outcome associated with morbidity and mortality in older adults but it is not routinely measured in people with chronic obstructive pulmonary disease (COPD). We aimed to validate a participation measure, the Late Life Disability Instrument (LLDI), in people with COPD. RESEARCH QUESTION To what extent does the LLDI demonstrate test-retest measurement error and reliability, internal consistency, construct and face validity, and floor/ceiling effects when applied to people with COPD? STUDY DESIGN and Methods: Cross-sectional study. LLDI scores were compared to scores on measures of theoretically-related constructs and between groups based on symptom severity, prognosis and frailty. A subsample (n=36) completed the LLDI a second time over the phone within one week. Participants and healthcare professionals (HCPs) were asked about the relevance, comprehensiveness and comprehensibility of the LLDI. Floor/ceiling effects were explored and the internal consistency (Cronbach's alpha) of the LLDI was calculated. RESULTS Ninety-six older adults with COPD participated. The frequency (LLDI-F) and limitation (LLDI-L) domains of the LLDI had excellent test-retest reliability (ICC2,1 0.90, SEM 1.74 points and ICC2,1 0.90, SEM 3.16 points, respectively). Both domains had fair correlations with physical function, depression, and quality of life (r = 0.38 to 0.59). The relationship with anxiety was poor for LLDI-F (r = -0.21) and fair for LLDI-L (r = -0.45). Both domains discriminated between people with different symptom severity, prognosis and frailty (p ≤ 0.026). Neither domain showed floor/ceiling effects and Cronbach's alpha was 0.69 and 0.91 for LLDI-F and LLDI-L, respectively. All HCPs and most participants agreed that the LLDI measures participation (79%) and that the items were relevant (81%). INTERPRETATION The LLDI shows test-retest reliability, internal consistency and construct and face validity in people with COPD. The LLDI can be used to assess participation in this population.

Keywords: participation; people copd; lldi; late life; life disability

Journal Title: Chest
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.